These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30595680)

  • 1. Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment.
    Kim AH; Yoon S; Lee Y; Lee J; Bae E; Lee H; Kim DK; Lee S; Yu KS; Jang IJ; Cho JY
    J Korean Med Sci; 2018 Dec; 33(53):e298. PubMed ID: 30595680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms.
    Oda A; Suzuki Y; Yoshijima C; Sato H; Tanaka R; Ono H; Tatsuta R; Ando T; Shin T; Itoh H; Ohno K
    Br J Clin Pharmacol; 2023 Dec; 89(12):3648-3658. PubMed ID: 37522799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females.
    Lee J; Kim AH; Yi S; Lee S; Yoon SH; Yu KS; Jang IJ; Cho JY
    AAPS J; 2017 Jul; 19(4):1196-1204. PubMed ID: 28523515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients.
    Suzuki Y; Muraya N; Fujioka T; Sato F; Tanaka R; Matsumoto K; Sato Y; Ohno K; Mimata H; Kishino S; Itoh H
    Pharmacol Rep; 2019 Apr; 71(2):276-281. PubMed ID: 30826567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma concentration of 4β-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients.
    Suzuki Y; Itoh H; Fujioka T; Sato F; Kawasaki K; Sato Y; Sato Y; Ohno K; Mimata H; Kishino S
    Drug Metab Dispos; 2014 Jan; 42(1):105-10. PubMed ID: 24135442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.
    Lee J; Yoon SH; Yi S; Kim AH; Kim B; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):247-252. PubMed ID: 31088714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 4β-hydroxycholesterol : cholesterol and 6β-hydroxycortisol : cortisol as markers of CYP3A4 induction.
    Mårde Arrhén Y; Nylén H; Lövgren-Sandblom A; Kanebratt KP; Wide K; Diczfalusy U
    Br J Clin Pharmacol; 2013 Jun; 75(6):1536-40. PubMed ID: 23116409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker.
    Kim AH; Kim B; Rhee SJ; Lee Y; Park JS; Lee SM; Kim SM; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2018 Jun; 33(3):173-178. PubMed ID: 29759884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects.
    Lee S; Lee Y; Kim AH; Yoon S; Lee J; Ji SC; Yoon SH; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2021 Feb; 36():100374. PubMed ID: 33348239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.
    Suzuki Y; Oda A; Negami J; Toyama D; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Lipid Res; 2022 Mar; 63(3):100184. PubMed ID: 35181316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of plasma lenvatinib concentrations and endogenous urinary cytochrome P450 3A activity biomarkers in clinical practice.
    Kumondai M; Ogawa R; Hayashi N; Ishida Y; Oshikiri H; Sato Y; Kikuchi M; Sato Y; Sato T; Maekawa M; Mano N
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1241. PubMed ID: 38992911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of CYP3A-specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β-hydroxycholesterol/cholesterol ratio.
    Lee J; Fallon JK; Smith PC; Jackson KD
    Clin Transl Sci; 2023 Feb; 16(2):279-291. PubMed ID: 36350327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
    Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
    AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinine compared to 4β-hydroxycholesterol and midazolam as markers for CYP3A induction by rifampicin.
    Björkhem-Bergman L; Bäckström T; Nylén H; Rönquist-Nii Y; Bredberg E; Andersson TB; Bertilsson L; Diczfalusy U
    Drug Metab Pharmacokinet; 2014; 29(4):352-5. PubMed ID: 24522201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography-mass spectrometry measurement of 6beta-OH-cortisol/cortisol ratio in human urine: a specific marker of enzymatic induction.
    Luceri F; Fattori S; Luceri C; Zorn M; Mannaioni P; Messeri G
    Clin Chem Lab Med; 2001 Dec; 39(12):1234-9. PubMed ID: 11798083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.
    Mao J; Martin I; McLeod J; Nolan G; van Horn R; Vourvahis M; Lin YS
    Drug Metab Rev; 2017 Feb; 49(1):18-34. PubMed ID: 27718639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity.
    Lutz U; Bittner N; Ufer M; Lutz WK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):97-101. PubMed ID: 19959402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers.
    Makhova AA; Shikh EV; Bulko TV; Sizova ZM; Shumyantseva VV
    Drug Metab Pers Ther; 2019 Oct; 34(3):. PubMed ID: 31603853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.
    Koike H; Morita T; Tatebe J; Watanabe I; Koike M; Yao S; Shinohara M; Yuzawa H; Suzuki T; Fujino T; Ikeda T
    Heart Vessels; 2019 Apr; 34(4):641-649. PubMed ID: 30406286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects.
    Lee S; Kim AH; Yoon S; Lee J; Lee Y; Ji SC; Yoon SH; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2021 Feb; 36():100368. PubMed ID: 33348240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.